— Know what they know.
Not Investment Advice
Also trades as: EMBCV (NASDAQ) · $vol 116M

EMBC NASDAQ

Embecta Corp.
1W: -1.9% 1M: -66.5% 3M: -70.5% YTD: -73.4% 1Y: -72.7% 3Y: -88.1%
$3.06
+0.16 (+5.52%)
 
Weekly Expected Move ±29.4%
$1 $2 $3 $4 $5
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Sell · Power 30 · $181.5M mcap · 58M float · 2.85% daily turnover · Short 52% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$181.5M
52W Range2.77-15.55
Volume2,699,647
Avg Volume1,666,167
Beta1.05
Dividend$0.60
Analyst Ratings
0 Buy 2 Hold 2 Sell
Consensus Hold
Company Info
CEODevdatt Kurdikar
Employees2,000
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-03-22
300 Kimball Drive
Parsippany, NJ 07054
US
201 847 6880
About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Recent Insider Trades

NameTypeSharesPriceDate
Anderson Carrie L A-Award 22,841 2026-02-11
HOMBACH ROBERT J. A-Award 22,841 2026-02-11
Morris Milton Mayo A-Award 22,841 2026-02-11
Prange Karen A-Award 22,841 2026-02-11
Pomeroy Claire A-Award 22,841 2026-02-11

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms